LYRA: Maintenance therapy with daratumumab improves depth of response and achieves durable remissions in MM patients

ELEVATE TN: Comparing acalabrutinib monotherapy or in combination with obinutuzumab in treatment-naïve CLL

Complete remission after induction chemotherapy determines clinical efficacy of relapse-preventive immunotherapy in AML

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma

Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia

Azacitidine plus nivolumab in older adults with AML or MDS

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy

Depth of response to daratumumab, lenalidomide, bortezomib, and dexamethasone improves over time in transplant-eligible newly diagnosed multiple myeloma

CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in patients with multiple myeloma